Common infectious agents in multiple sclerosis: A case-control study in children

Multiple Sclerosis

Volumn 14, Issue 1, 2008, Pages 136-139

  Krone, Bernd ^a   Pohl, Daniela ^a   Rostasy, Kevin ^a,b   Kahler, Elke ^a   Brunner, Edgar ^a   Oeffner, Frank ^a,c   Grange, John M ^d   Gärtner, Jutta ^a   Hanefeld, Folker ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Childhood infections; Epstein Barr virus; Paediatric multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; HUMAN CELL; INFECTION; INFLUENZA; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; MEASLES; MULTIPLE SCLEROSIS; ONSET AGE; PARAINFLUENZA VIRUS 2; PREVALENCE; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; BLOOD; EPIDEMIOLOGY; GERMANY; IMMUNOLOGY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MULTIPLE SCLEROSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; VIRUS DISEASES;

EID: 42149170554     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458507082069     Document Type: Article

References (16)

1. Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B. Epstein-Barr virus in pediatric multiple sclerosis. J Amer Med Assoc 2004; 291: 1875-79.
2. Pohl D, Krone B, Rostasy K, Kahler E. Brunner E, Lehnert M, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 2006; 67: 2063-65.
3. Norby E. Viral antibodies in multiple sclerosis. Prog Med Virol 1978; 24: 1-39.
4. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand 1995; (Suppl) 161: 34-42.
5. Simmons A. Herpesviruses and multiple sclerosis. Herpes 2001; 8: 60-3.
6. Haahr S, Höllsberg P. The ability of candidate viruses to explain epidemiological findings in multiple sclerosis. In: Hommes OR, Clanet M, Wekerle H eds. Genes and viruses in multiple sclerosis. Amsterdam: Elsevier; 2001: 163-84.
7. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis - are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 2003; 136: 1-8.
8. Munzel U. Nonparametric methods for paired samples. Statistica Neerlandica 1999; 53: 277-86.
9. Haahr S, Höllsberg P. Multiple sclerosis is linked to Epstein-Barr virus infection. Rev Med Virol 2006; 16: 297-310.
10. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J Amer Med Assoc 2005; 293: 2469-500.
11. DeLorenze GN, Munger KL, Lenette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up. Arch Neurol 2006; 63: 839-44.
12. Catalano LW Jr. Herpesvirus hominis antibody in multiple sclerosis and amyotropic lateral sclerosis. Neurology 1972; 22: 473-8.
13. MacGregor HS, Latiwonk QI. Complex role of gamma-herpesviruses in multiple sclerosis and infectious mononucleosis. Neurol Res 1993; 15: 391-4.
14. Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006; 12: 397-411.
15. Munger KL, DeLorenze GN, Levin LI, Rubertone MV, Vogelman JH, Peck CA, et al. A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts. Neurology 2004; 25: 1799-803.
16. Reinhardt D, Houliara K, Pekrun A, Lakomek M, Krone B. Impact of conventional chemotherapy on levels of antibodies against vaccine-preventable diseases in children treated for cancer. Scand J Infect Dis 2003; 35: 851-57.